Abstract
LGI1 is a multifunctional brain protein whose dysfunction is related to several neurologic disorders as diverse as autosomal dominant lateral temporal epilepsy (ADLTE), autoimmune limbic encephalitis (LE), and glioma tumor progression. ADLTE is a genetic focal epilepsy characterized by auditory or aphasic aura and onset in infancy/adolescence, whereas autoimmune LE occurs in adult life and is characterized by amnesia, confusion, and seizures. The complex molecular mechanisms underlying these epileptic conditions are largely unknown. In this chapter, I outline the clinical features, the genetic or autoimmune causes, and a molecular mechanism possibly underlying both ADLTE and autoimmune LE.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Berghuis B, Brilstra EH, Lindhout D et al (2013) Hyperactive behavior in a family with autosomal dominant lateral temporal lobe epilepsy caused by a mutation in the LGI1/epitempin gene. Epilepsy Behav 28:41–46
Berkovic SF, Izzillo P, McMahon JM et al (2004) LGI1 mutations in temporal lobe epilepsies. Neurology 62:1115–1119
Bisulli F, Tinuper P, Avoni P et al (2004a) Idiopathic partial epilepsy with auditory features (IPEAF): a clinical and genetic study of 53 sporadic cases. Brain 127:1343–1352
Bisulli F, Tinuper P, Scudellaro E et al (2004b) A de novo LGI1 mutation in sporadic partial epilepsy with auditory features. Ann Neurol 56:455–456
Brodtkorb E, Michler RP, Gu W et al (2005) Speech-induced aphasic seizures in epilepsy caused by LGI1 mutation. Epilepsia 46:963–966
Chabrol E, Popescu C, Gourfinkel-An I et al (2007) Two novel epilepsy-linked mutations leading to a loss of function of LGI1. Arch Neurol 64:217–222
Chabrol E, Navarro V, Provenzano G et al (2010) Electroclinical characterization of epileptic seizures in leucine-rich, glioma-inactivated 1- deficient mice. Brain 133:2749–2762
Chernova OB, Somerville RP, Cowell JK (1998) A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors. Oncogene 17:2873–2881
Dalmau J, Gleichman AJ, Hughes EG et al (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098
de Bellescize J, Boutry N, Chabrol E et al (2009) A novel three base-pair LGI1 deletion leading to loss of function in a family with autosomal dominant lateral temporal epilepsy and migraine-like episodes. Epilepsy Res 85:118–122
Di Bonaventura C, Carni M, Diani E et al (2009) Drug resistant ADLTE and recurrent partial status epilepticus with dysphasic features in a family with a novel LGI1 mutation: electroclinical, genetic, and EEG/fMRI findings. Epilepsia 50:2481–2486
Di Bonaventura C, Operto FF, Busolin G et al (2011) Low penetrance and effect on protein secretion of LGI1 mutations causing autosomal dominant lateral temporal epilepsy. Epilepsia 52:1258–1264
Fertig E, Lincoln A, Martinuzzi A et al (2003) Novel LGI1 mutation in a family with autosomal dominant partial epilepsy with auditory features. Neurology 60:1687–1690
Fanciulli M, Santulli L, Errichiello L et al (2012) LGI1 microdeletion in autosomal dominant lateral temporal epilepsy. Neurology 78:1299–1303
Fukata Y, Adesnik H, Iwanaga T et al (2006) Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science 313:1792–1795
Fukata Y, Lovero KL, Iwanaga T et al (2010) Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc Natl Acad Sci U S A 107:3799–3804
Gable MS, Gavali S, Radner A et al (2009) Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 28:1421–1429
Gu W, Brodtkorb E, Steinlein OK (2002) LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures. Ann Neurol 52:364–367
Hart IK, Waters C, Vincent A et al (1997) Autoantibodies detected to expressed Kþ channels are implicated in neuromyotonia. Ann Neurol 41:238–246
Hart IK, Maddison P, Newsom-Davis J et al (2002) Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 125:1887–1895
Hedera P, Abou-Khalil B, Crunk AE et al (2004) Autosomal dominant lateral temporal epilepsy: two families with novel mutations in the LGI1 gene. Epilepsia 45:218–222
Heiman GA, Kamberakis K, Gill R et al (2010) Evaluation of depression risk in LGI1 mutation carriers. Epilepsia 51:1685–1690
Ho YY, Ionita-Laza I, Ottman R (2012) Domain-dependent clustering and genotype-phenotype analysis of LGI1 mutations in ADPEAF. Neurology 78:563–568
Irani SR, Buckley C, Vincent A et al (2008) Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology 71:1647–1648
Irani SR, Alexander S, Waters P et al (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 133:2734–2748
Irani SR, Michell AW, Lang B et al (2011) Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 69:892–900
Irani SR, Pettingill P, Kleopa KA et al (2012) Morvan syndrome: Clinical and serological observations in 29 cases. Ann Neurol 72:241–255
Irani SR, Charlotte JS, Schott JM et al (2013) Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain 136:3151–3162
Kalachikov S, Evgrafov O, Ross B et al (2002) Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet 30:335–341
Kawamata J, Ikeda A, Fujita Y et al (2010) Mutations in LGI1 gene in Japanese families with autosomal dominant lateral temporal lobe epilepsy: the first report from Asian families. Epilepsia 51:690–693
Kobe B, Kajava AV (2001) The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 11:725–732
Kunapuli P, Chitta KS, Cowell JK (2003) Suppression of the cell proliferation and invasion phenotypes in glioma cells by the LGI1 gene. Oncogene 22:3985–3991
Kunapuli P, Kasyapa CS, Hawthorn L et al (2004) LGI1, a putative tumor metastasis suppressor gene, controls in vitro invasiveness and expression of matrix metalloproteinases in glioma cells through the ERK1/2 pathway. J Biol Chem 279:23151–23157
Leonardi E, Andreazza S, Vanin S et al (2011) A computational model of the LGI1 protein suggests a common binding site for ADAM proteins. Plos One 6:e18142
Lai M, Huijbers MGM, Lancaster E et al (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9:776–785
Lee MK, Kim SW, Lee JH et al (2014) A Newly discovery of LGI1 mutation in a Korean family with autosomal dominant lateral temporal lobe epilepsy. Seizure 23:69–73
Michelucci R, Poza JJ, Sofia V et al (2003) Autosomal dominant lateral temporal epilepsy: clinical spectrum, new epitempin mutations, and genetic heterogeneity in seven European families. Epilepsia 44:1289–1297
Michelucci R, Mecarelli O, Bovo G et al (2007) A de novo LGI1 mutation causing idiopathic partial epilepsy with telephone-induced seizures. Neurology 68:2150–2151
Michelucci R, Pasini E, Nobile C (2009) Lateral temporal lobe epilepsies: clinical and genetic features. Epilepsia 50(Suppl 5):52–54
Michelucci R, Pasini E, Malacrida S et al (2013) Low penetrance of autosomal dominant lateral temporal epilepsy in Italian families without LGI1 mutations. Epilepsia 54:1288–1297
Morante-Redolat JM, Gorostidi-Pagola A, Piquer-Sirerol S et al (2002) Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. Hum Mol Genet 11:1119–1128
Nobile C, Michelucci R, Andreazza S et al (2009) LGI1 mutations in autosomal dominant and sporadic lateral temporal epilepsy. Hum Mutat 30:530–536
Ohkawa T, Fukata Y, Yamasaki M et al (2013) Autoantibodies to Epilepsy-Related LGI1 in Limbic Encephalitis Neutralize LGI1-ADAM22 Interaction and Reduce Synaptic AMPA Receptors. J Neurosci 33:18161–18174
Owuor K, Harel NY, Englot DJ et al (2009) LGI1-associated epilepsy through altered ADAM23-dependent neuronal morphology. Mol Cell Neurosci 42:448–457
Ottman R, Risch N, Hauser WA et al (1995) Localization of a gene for partial epilepsy to chromosome 10q. Nat Genet 10:56–60
Ottman R, Winawer MR, Kalachikov S et al (2004) LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology 62:1120–1126
Paoli M (2001) Protein folds propelled by diversity. Prog Biophys Molec Biol 76:103–130
Piepoli T, Jakupoglu C, Gu W et al (2006) Expression studies in gliomas and glial cells do not support a tumor suppressor role for LGI1. Neuro Oncol 8:96–108
Pisano T, Marini C, Brovedani P et al (2005) Abnormal phonologic processing in familial lateral temporal lobe epilepsy due to a new LGI1 mutation. Epilepsia 46:118–123
Pizzuti A, Flex E, Di Bonaventura C et al (2003) Epilepsy with auditory features: a LGI1 gene mutation suggests a loss-of-function mechanism. Ann Neurol 53:396–399. Erratum in. Ann Neurol 2003;54:137
Rosanoff MJ, Ottman R (2008) Penetrance of LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology 71:567–571
Sadleir LG, Agher D, Chabrol E et al (2013) Seizure semiology in autosomal dominant epilepsy with auditory features, due to novel LGI1 mutations. Epilepsy Res 107:311–317
Sagane K, Hayakawa K, Kaj J et al (2005) Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice. BMC Neurosci 6:33
Schulte U, Thumfart JO, Klocker N et al (2006) The epilepsy-linked Lgi1 protein assembles into presynaptic kv1 channels and inhibits inactivation by Kvbeta1. Neuron 49:697–706
Senechal KR, Thaller C, Noebels JL (2005) ADPEAF mutations reduce levels of secreted LGI1, a putative tumor suppressor protein linked to epilepsy. Hum Mol Genet 14:1613–1620
Somerville RP, Chernova O, Liu S et al (2000) Identification of the promoter, genomic structure, and mouse ortholog of LGI1. Mamm Genome 11:622–627
Staub E, Perez-Tur J, Siebert R et al (2002) The novel EPTP repeat defines a superfamily of proteins implicated in epileptic disorders. Trends Biochem Sci 27:441–444
Striano P, de Falco A, Diani E et al (2008) A novel loss-of-function LGI1 mutation linked to autosomal dominant lateral temporal epilepsy. Arch Neurol 65:939–942
Striano P, Busolin G, Santulli L et al (2011) Familial temporal lobe epilepsy with psychic auras associated with a novel LGI1 mutation. Neurology 76:1173–1176
Tan KM, Lennon VA, Klein CJ et al (2008) Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 70:1883–1890
Tessa C, Michelucci R, Nobile C et al (2007) Structural anomaly of left lateral temporal lobe in epilepsy due to mutated LGI1. Neurology 69:1298–1300
Vincent A, Buckley C, Schott JM et al (2004) Potassium channel antibodyassociated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127:701–712
Vincent A, Bien CG, Irani SR et al (2011) Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 10:759–772
Warmolts JR, Mendell JR (1980) Neurotonia: impulse-induced repetitive discharges in motor nerves in peripheral neuropathy. Ann Neurol 7:245–250
Yu YE, Wen L, Silva J et al (2010) Lgi1 null mutant mice exhibit myoclonic seizures and CA1 neuronal hyperexcitability. Hum Mol Genet 19:1702–1711
Zhou YD, Lee S, Jin Z et al (2009) Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. Nat Med 15:1208–1214
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Nobile, C. (2015). LGI1 Dysfunction in Inherited and Acquired Epileptic Disorders. In: Striano, P. (eds) Epilepsy Towards the Next Decade. Contemporary Clinical Neuroscience. Springer, Cham. https://doi.org/10.1007/978-3-319-12283-0_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-12283-0_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-12282-3
Online ISBN: 978-3-319-12283-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)